Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free TBI Stock Alerts

TrueBlue (TBI) Financials

TrueBlue logo
$6.78 -0.44 (-6.02%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$6.76 -0.03 (-0.44%)
As of 07/2/2026 05:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for TrueBlue

Annual Income Statements for TrueBlue

This table shows TrueBlue's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/25/2015 1/1/2017 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/25/2022 12/31/2023 12/29/2024 12/28/2025
Net Income / (Loss) Attributable to Common Shareholders		 71 -15 55 66 63 -142 62 58 -15 -127 -47
Consolidated Net Income / (Loss)		 71 -15 55 66 63 -142 62 62 -14 -126 -48
Net Income / (Loss) Continuing Operations		 71 -15 55 66 63 -142 62 62 -14 -126 -48
Total Pre-Tax Income 		96 -20 78 76 70 -173 74 73 -21 -89 -46
Total Operating Income		 98 -17 78 74 66 -175 68 72 -24 -93 -47
Total Gross Profit		 636 680 634 655 620 441 560 602 506 406 368
Total Revenue		 2,696 2,751 2,509 2,499 2,369 1,846 2,174 2,254 1,906 1,567 1,616
Operating Revenue		 2,696 2,751 2,509 2,499 2,369 1,846 2,174 2,254 1,906 1,567 1,616
Total Cost of Revenue		 2,060 2,071 1,874 1,844 1,749 1,406 1,613 1,652 1,400 1,161 1,248
Operating Cost of Revenue		 2,060 2,071 1,874 1,844 1,749 1,406 1,613 1,652 1,400 1,161 1,248
Total Operating Expenses		 538 697 557 582 554 616 492 530 530 499 414
Selling, General & Admin Expense		 496 546 511 540 516 408 464 501 495 411 371
Depreciation Expense		 42 47 46 41 38 32 28 29 26 29 25
Impairment Charge		 0.00 104 - 0.00 0.00 175 0.00 0.00 9.49 60 19
Total Other Income / (Expense), net		 -1.40 -3.35 -0.01 1.74 3.87 1.62 5.41 1.23 3.21 4.25 1.00
Interest & Investment Income		 2.77 3.82 5.48 1.74 3.87 1.62 5.41 1.23 3.21 4.25 1.00
Income Tax Expense		 25 -5.09 22 9.91 6.97 -31 12 11 -6.47 37 2.33
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - - - - - - 4.27 0.69 1.48 -0.55
Basic Earnings per Share		 $1.73 ($0.37) $1.35 $1.64 $1.63 ($4.01) $1.77 $1.89 ($0.45) ($4.17) ($1.61)
Weighted Average Basic Shares Outstanding		 41.23M 41.65M 41.20M 39.99M 38.78M 35.37M 34.80M 32.89M 31.32M 30.18M 29.85M
Diluted Earnings per Share		 $1.71 ($0.37) $1.34 $1.63 $1.61 ($4.01) $1.74 $1.86 ($0.45) ($4.17) ($1.61)
Weighted Average Diluted Shares Outstanding		 41.62M 41.65M 41.44M 40.28M 39.18M 35.37M 35.43M 33.45M 31.32M 30.18M 29.85M
Weighted Average Basic & Diluted Shares Outstanding		 41.20M 41.20M 41.10M 40.10M 38.63M 35.49M 34.46M 32.82M 31.39M 29.71M 30.06M

Quarterly Income Statements for TrueBlue

This table shows TrueBlue's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/24/2023 12/31/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026
Net Income / (Loss) Attributable to Common Shareholders		 -1.32 -2.19 -1.76 -104 -7.20 -14 -14 0.48 -2.14 -31 -20
Consolidated Net Income / (Loss)		 -0.01 -2.55 -1.70 -105 -7.64 -12 -14 -0.16 -1.92 -32 -20
Net Income / (Loss) Continuing Operations		 -0.01 -2.55 -1.70 -105 -7.64 -12 -14 -0.16 -1.92 -32 -20
Total Pre-Tax Income 		-2.34 -7.40 -14 -58 -6.38 -10 -14 -0.04 -1.21 -30 -19
Total Operating Income		 -2.73 -8.63 -16 -60 -6.90 -10 -14 -2.94 -0.15 -29 -18
Total Gross Profit		 124 128 99 104 100 103 86 94 98 90 79
Total Revenue		 473 492 403 396 382 386 370 396 431 418 399
Operating Revenue		 473 492 403 396 382 386 370 396 431 418 399
Total Cost of Revenue		 349 364 303 292 282 283 284 303 333 328 320
Operating Cost of Revenue		 349 364 303 292 282 283 284 303 333 328 320
Total Operating Expenses		 127 137 115 164 107 113 100 97 98 119 97
Selling, General & Admin Expense		 121 130 107 97 100 107 95 90 92 95 87
Depreciation Expense		 6.18 6.95 7.96 7.69 6.97 6.01 5.84 6.51 6.31 6.16 5.91
Impairment Charge		 0.00 - - 60 0.00 - 0.00 0.20 0.00 - 3.66
Total Other Income / (Expense), net		 0.39 1.22 1.60 1.74 0.52 0.39 0.19 2.90 -1.06 -1.03 -1.37
Other Income / (Expense), net		 0.39 - 1.60 1.74 0.52 - 0.19 2.90 -1.06 - -1.37
Income Tax Expense		 -2.33 -4.85 -12 46 1.25 1.69 0.42 0.12 0.71 1.08 0.58
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 1.31 -0.36 0.06 -0.22 -0.44 2.08 0.03 -0.64 0.22 -0.16 0.04
Basic Earnings per Share		 $0.00 ($0.08) ($0.05) ($3.45) ($0.26) ($0.41) ($0.48) ($0.01) ($0.06) ($1.06) ($0.66)
Weighted Average Basic Shares Outstanding		 30.93M 31.32M 31.10M 30.35M 29.70M 30.18M 29.70M 29.86M 29.90M 29.85M 30.15M
Diluted Earnings per Share		 $0.00 ($0.08) ($0.05) ($3.45) ($0.26) ($0.41) ($0.48) ($0.01) ($0.06) ($1.06) ($0.66)
Weighted Average Diluted Shares Outstanding		 30.93M 31.32M 31.10M 30.35M 29.70M 30.18M 29.70M 29.86M 29.90M 29.85M 30.15M
Weighted Average Basic & Diluted Shares Outstanding		 31.14M 31.39M 30.57M 29.83M 29.56M 29.71M 29.86M 29.90M 29.94M 30.06M 30.40M

Annual Cash Flow Statements for TrueBlue

This table details how cash moves in and out of TrueBlue's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/25/2015 1/1/2017 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/25/2022 12/31/2023 12/29/2024 12/28/2025
Net Change in Cash & Equivalents		 10 22 -30 30 -10 26 -15 32 -36 -38 -17
Net Cash From Operating Activities		 72 261 100 126 94 153 20 121 35 -17 -58
Net Cash From Continuing Operating Activities		 72 261 100 126 94 153 20 121 35 -17 -58
Net Income / (Loss) Continuing Operations		 71 -15 55 66 63 -142 62 62 -14 -126 -48
Consolidated Net Income / (Loss)		 71 -15 55 66 63 -142 62 62 -14 -126 -48
Depreciation Expense		 42 47 46 41 38 32 28 29 26 30 29
Non-Cash Adjustments To Reconcile Net Income		 19 128 17 29 31 205 41 35 37 77 35
Changes in Operating Assets and Liabilities, net		 -60 101 -18 -10 -38 57 -110 -6.09 -14 2.28 -74
Net Cash From Investing Activities		 -105 -124 -54 -21 -22 -34 -16 -21 -32 -2.45 -16
Net Cash From Continuing Investing Activities		 -105 -124 -54 -21 -22 -34 -16 -21 -32 -2.45 -16
Purchase of Property, Plant & Equipment		 -18 -29 -22 -17 -28 -27 -35 -31 -31 -24 -16
Acquisitions		 -68 -72 0.00 -23 - - - - 0.00 0.00 -30
Purchase of Investments		 -52 -43 -51 -13 -31 -35 -9.45 -18 -34 -11 -11
Divestitures		 - 0.00 0.00 11 - - - 0.00 0.00 3.10 0.40
Sale and/or Maturity of Investments		 14 17 20 22 49 40 31 28 34 34 40
Other Investing Activities, net		 18 2.98 -1.98 0.00 -12 -12 -3.03 0.00 -0.69 -4.00 0.30
Net Cash From Financing Activities		 43 -115 -75 -75 -83 -93 -19 -65 -38 -17 57
Net Cash From Continuing Financing Activities		 43 -115 -75 -75 -83 -93 -19 -65 -38 -17 57
Repayment of Debt		 -2.08 -108 -19 -38 -43 -39 -0.35 -0.25 -0.10 5.79 58
Repurchase of Common Equity		 0.00 -5.75 -37 -35 -39 -52 -17 -61 -34 -21 0.00
Issuance of Common Equity		 1.56 1.54 1.65 1.50 1.33 0.92 1.14 0.98 0.86 0.74 0.45
Other Financing Activities, net		 -3.87 -2.85 -21 -3.40 -2.22 -2.44 -3.24 -4.48 -4.16 -2.33 -1.10
Effect of Exchange Rate Changes		 0.28 - - - 0.94 0.62 -0.52 -2.42 -0.87 -1.61 -0.12
Cash Interest Paid		 3.50 4.08 3.81 4.37 2.43 3.15 1.43 1.12 1.03 1.04 4.62
Cash Income Taxes Paid		 34 10 4.59 13 12 -3.44 9.77 9.98 5.17 0.21 -4.85

Quarterly Cash Flow Statements for TrueBlue

This table details how cash moves in and out of TrueBlue's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/24/2023 12/31/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026
Net Change in Cash & Equivalents		 -17 8.75 -28 -15 -7.58 12 3.06 -12 -1.66 -6.77 0.29
Net Cash From Operating Activities		 -1.30 15 -14 -1.82 -7.13 6.13 -22 -12 -20 -4.37 -9.78
Net Cash From Continuing Operating Activities		 -1.30 15 -14 -1.82 -7.13 6.13 -22 -12 -20 -4.37 -9.78
Net Income / (Loss) Continuing Operations		 -0.01 -2.55 -1.70 -105 -7.64 -12 -14 -0.16 -1.92 -32 -20
Consolidated Net Income / (Loss)		 -0.01 -2.55 -1.70 -105 -7.64 -12 -14 -0.16 -1.92 -32 -20
Depreciation Expense		 6.18 6.95 7.96 7.69 6.97 6.95 6.81 7.50 7.35 7.20 6.87
Non-Cash Adjustments To Reconcile Net Income		 8.41 6.38 2.53 66 2.79 5.83 6.55 2.59 2.45 23 11
Changes in Operating Assets and Liabilities, net		 -16 4.41 -23 29 -9.25 5.06 -21 -22 -28 -3.04 -7.97
Net Cash From Investing Activities		 -14 -5.77 0.92 -6.23 3.87 -1.02 -24 4.18 3.70 0.03 3.22
Net Cash From Continuing Investing Activities		 -14 -5.77 0.92 -6.23 3.87 -1.02 -24 4.18 3.70 0.03 3.22
Purchase of Property, Plant & Equipment		 -7.36 -8.18 -7.38 -5.90 -5.60 -5.28 -4.68 -4.26 -3.62 -3.13 -2.83
Acquisitions		 - - 0.00 - - - -30 -0.10 -0.04 0.03 0.00
Purchase of Investments		 -17 -7.22 -10 - - -1.06 0.00 - -3.94 -6.94 -7.72
Sale and/or Maturity of Investments		 8.51 9.63 16 3.67 9.47 5.15 11 8.53 11 9.77 14
Net Cash From Financing Activities		 -1.03 -0.25 -14 -6.86 -4.25 7.68 49 -4.25 14 -2.45 7.17
Net Cash From Continuing Financing Activities		 -1.03 -0.25 -14 -6.86 -4.25 7.68 49 -4.25 14 -2.45 7.17
Repayment of Debt		 -0.01 -0.00 -1.80 -0.00 - 7.60 50 -51 61 -2.41 7.61
Issuance of Common Equity		 0.20 0.15 0.22 0.20 0.15 0.17 0.07 0.19 0.11 0.09 0.16
Other Financing Activities, net		 -1.25 -0.40 -2.01 -0.13 -0.08 -0.10 -0.90 -0.05 -0.03 -0.12 -0.60
Effect of Exchange Rate Changes		 -0.74 -0.12 -0.60 0.05 -0.08 -0.97 -0.23 - - 0.02 -0.32
Cash Interest Paid		 0.27 0.31 0.24 0.25 0.28 0.27 0.36 1.19 1.31 1.77 1.56
Cash Income Taxes Paid		 0.97 0.44 -1.08 0.88 0.75 -0.34 0.12 0.46 -2.07 -3.34 0.38

Annual Balance Sheets for TrueBlue

This table presents TrueBlue's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/25/2015 1/1/2017 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/25/2022 12/31/2023 12/29/2024 12/28/2025
Total Assets		 1,259 1,130 1,109 1,115 1,136 981 1,033 1,019 899 675 639
Total Current Assets		 543 428 428 430 422 379 445 430 355 277 298
Cash & Equivalents		 30 35 29 47 38 63 50 72 62 23 25
Accounts Receivable		 461 353 374 355 342 278 354 314 253 215 241
Prepaid Expenses		 24 21 21 22 31 26 32 33 29 32 31
Current Deferred & Refundable Income Taxes		 28 19 4.62 5.33 11 12 9.68 11 12 8.07 0.88
Plant, Property, & Equipment, net		 58 64 60 58 66 72 88 96 105 90 73
Total Noncurrent Assets		 659 639 621 627 648 530 500 493 439 309 268
Long-Term Investments		 188 231 239 235 231 241 221 214 193 180 137
Noncurrent Note & Lease Receivables		 - - 45 45 45 53 61 75 54 38 26
Goodwill		 268 224 227 237 237 95 95 94 84 25 42
Intangible Assets		 154 126 105 91 74 29 22 16 11 5.86 18
Noncurrent Deferred & Refundable Income Taxes		 0.00 6.77 3.78 4.39 3.23 30 29 26 35 0.89 1.34
Other Noncurrent Operating Assets		 48 51 1.22 14 58 83 72 69 63 59 44
Total Liabilities & Shareholders' Equity		 1,259 1,130 1,109 1,115 1,136 981 1,033 1,019 899 675 639
Total Liabilities		 724 605 554 523 510 543 540 523 442 360 364
Total Current Liabilities		 228 251 212 226 231 269 259 243 204 160 139
Accounts Payable		 70 67 55 62 68 58 77 77 56 46 36
Accrued Expenses		 - - - - 68 123 100 92 80 61 62
Current Deferred & Payable Income Tax Liabilities		 - - - - - - 0.00 1.14 0.44 0.32 1.04
Current Employee Benefit Liabilities		 155 159 154 154 73 66 62 50 45 35 24
Other Current Liabilities		 2.87 25 3.22 9.96 22 22 20 23 22 18 15
Total Noncurrent Liabilities		 496 354 342 298 279 274 282 280 237 200 226
Long-Term Debt		 243 135 116 80 37 - - - 0.00 7.60 66
Noncurrent Employee Benefit Liabilities		 197 213 219 212 209 216 223 227 187 143 112
Other Noncurrent Operating Liabilities		 36 5.60 6.31 6.11 33 59 58 53 51 49 48
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 536 525 555 591 626 437 493 496 458 315 275
Total Preferred & Common Equity		 536 525 555 591 626 437 493 496 458 315 275
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 536 525 555 591 626 437 493 496 458 315 275
Common Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Retained Earnings		 550 537 562 606 639 452 509 516 479 338 296
Accumulated Other Comprehensive Income / (Loss)		 -14 -11 -6.80 -15 -13 -15 -16 -20 -21 -22 -22

Quarterly Balance Sheets for TrueBlue

This table presents TrueBlue's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/24/2023 3/31/2024 6/30/2024 9/29/2024 3/30/2025 6/29/2025 9/28/2025 3/29/2026
Total Assets		 915 869 724 702 692 673 691 621
Total Current Assets		 360 315 301 285 281 287 313 301
Cash & Equivalents		 47 36 26 15 23 22 20 24
Accounts Receivable		 276 244 231 225 219 226 252 246
Prepaid Expenses		 23 25 33 35 31 35 40 30
Current Deferred & Refundable Income Taxes		 13 10 11 11 7.67 4.33 1.28 0.87
Plant, Property, & Equipment, net		 103 104 92 91 88 85 82 69
Total Noncurrent Assets		 453 449 331 326 324 301 295 250
Long-Term Investments		 199 188 183 180 170 154 150 129
Noncurrent Note & Lease Receivables		 62 52 50 49 33 28 27 20
Goodwill		 85 84 25 25 42 43 42 39
Intangible Assets		 12 9.00 7.03 6.43 20 19 19 17
Noncurrent Deferred & Refundable Income Taxes		 29 51 1.38 0.73 0.88 0.88 1.10 1.24
Other Noncurrent Operating Assets		 66 65 64 65 57 56 57 43
Total Liabilities & Shareholders' Equity		 915 869 724 702 692 673 691 621
Total Liabilities		 458 422 386 375 390 368 386 365
Total Current Liabilities		 201 184 158 155 156 148 156 144
Accounts Payable		 49 44 36 36 38 37 39 40
Accrued Expenses		 87 81 66 65 66 61 67 66
Current Deferred & Payable Income Tax Liabilities		 0.16 0.00 0.00 0.00 4.08 0.62 0.38 1.05
Current Employee Benefit Liabilities		 44 41 39 37 31 28 28 23
Other Current Liabilities		 20 18 17 17 16 21 21 14
Total Noncurrent Liabilities		 258 238 228 221 234 220 230 221
Long-Term Debt		 - - - - 58 54 68 74
Noncurrent Employee Benefit Liabilities		 205 184 177 168 128 119 114 101
Other Noncurrent Operating Liabilities		 53 55 51 53 48 46 48 46
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 457 446 338 327 302 305 304 256
Total Preferred & Common Equity		 457 446 338 327 302 305 304 256
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 457 446 338 327 302 305 304 256
Common Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Retained Earnings		 478 467 358 347 324 327 326 278
Accumulated Other Comprehensive Income / (Loss)		 -21 -21 -21 -20 -22 -22 -22 -22

Annual Metrics And Ratios for TrueBlue

This table displays calculated financial ratios and metrics derived from TrueBlue's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/25/2015 1/1/2017 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/25/2022 12/31/2023 12/29/2024 12/28/2025
DEI Shares Outstanding		 41,967,937.00 42,478,596.00 41,361,507.00 40,485,261.00 38,955,288.00 35,472,768.00 35,480,624.00 32,718,640.00 31,139,746.00 - 29,939,468.00
DEI Adjusted Shares Outstanding		 41,967,937.00 42,478,596.00 41,361,507.00 40,485,261.00 38,955,288.00 35,472,768.00 35,480,624.00 32,718,640.00 31,139,746.00 - 29,939,468.00
DEI Earnings Per Adjusted Shares Outstanding		 1.70 -0.36 1.34 1.62 1.62 -4.00 1.74 1.77 -0.48 - -1.58
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 23.99% 2.04% -8.79% -0.38% -5.22% -22.05% 17.72% 3.71% -15.44% -17.78% 3.10%
EBITDA Growth		 25.61% -78.74% 316.47% -7.04% -9.78% -237.72% 167.20% 5.69% -98.06% -3,307.20% 71.87%
EBIT Growth		 19.72% -117.37% 556.39% -4.70% -10.47% -364.26% 139.14% 5.47% -133.04% -288.99% 49.73%
NOPAT Growth		 10.21% -116.46% 566.24% 15.82% -7.23% -305.42% 146.66% 7.19% -127.27% -288.99% 49.73%
Net Income Growth		 8.48% -121.41% 463.62% 18.57% -4.08% -324.88% 143.45% 1.04% -122.76% -787.24% 61.86%
EPS Growth		 7.55% -121.64% 462.16% 21.64% -1.23% -349.07% 143.39% 6.90% -124.19% -826.67% 61.39%
Operating Cash Flow Growth		 51.65% 261.73% -61.59% 25.52% -25.59% 63.08% -86.60% 489.55% -71.16% -149.08% -240.26%
Free Cash Flow Firm Growth		 96.67% 1,748.12% -69.89% 68.87% -31.17% 155.17% -122.38% 335.94% -112.59% 291.40% -620.67%
Invested Capital Growth		 17.04% -29.67% 2.27% -3.55% 1.42% -66.00% 65.60% -5.23% -3.57% -40.64% 48.75%
Revenue Q/Q Growth		 4.63% -2.68% -2.54% -0.77% -2.43% -3.77% 4.99% -2.77% -3.32% -6.35% 2.03%
EBITDA Q/Q Growth		 1.80% -21.40% -0.32% -6.47% -9.42% 0.56% 14.20% -12.88% -88.91% -2.90% -1,897.98%
EBIT Q/Q Growth		 1.44% -132.20% 0.20% -8.38% -12.60% 1.02% 23.04% -17.30% -185.05% -1.95% -68.88%
NOPAT Q/Q Growth		 1.63% -132.20% -3.59% -3.51% -10.87% 1.02% 23.52% -14.53% -185.05% -1.95% -68.88%
Net Income Q/Q Growth		 1.63% -194.99% -2.91% -2.29% -8.91% -0.49% 24.64% -17.45% -209.66% -7.85% -70.50%
EPS Q/Q Growth		 1.18% -184.62% -1.47% -2.98% -7.47% -5.80% 46.22% -15.84% -181.25% -8.59% -67.71%
Operating Cash Flow Q/Q Growth		 -33.23% 58.00% -21.91% 42.87% -14.66% 9.14% -62.37% 20.55% -42.07% -113.12% -22.08%
Free Cash Flow Firm Q/Q Growth		 -111.88% 2,149.37% -33.54% 62.76% -23.51% 12.58% -2,661.34% 45.88% -151.42% 21.37% -1.82%
Invested Capital Q/Q Growth		 32.31% -4.24% 0.99% -6.87% -4.67% -19.98% 4.45% -10.18% -3.65% -9.07% -11.68%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 23.58% 24.71% 25.29% 26.23% 26.17% 23.87% 25.78% 26.71% 26.55% 25.93% 22.76%
EBITDA Margin		 5.18% 1.08% 4.93% 4.60% 4.38% -7.74% 4.42% 4.50% 0.10% -4.03% -1.10%
Operating Margin		 3.63% -0.62% 3.09% 2.96% 2.79% -9.47% 3.15% 3.20% -1.25% -5.92% -2.89%
EBIT Margin		 3.63% -0.62% 3.09% 2.96% 2.79% -9.47% 3.15% 3.20% -1.25% -5.92% -2.89%
Profit (Net Income) Margin		 2.64% -0.55% 2.21% 2.63% 2.66% -7.68% 2.84% 2.76% -0.74% -8.02% -2.97%
Tax Burden Percent		 73.87% 74.98% 71.51% 86.90% 90.05% 81.87% 83.46% 84.82% 68.65% 142.05% 105.10%
Interest Burden Percent		 98.57% 119.68% 99.98% 102.36% 105.84% 99.07% 107.90% 101.71% 86.56% 95.42% 97.85%
Effective Tax Rate		 26.13% 0.00% 28.49% 13.10% 9.95% 0.00% 16.54% 15.18% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 13.90% -2.49% 13.91% 16.22% 15.21% -46.31% 32.06% 28.30% -8.07% -40.15% -21.78%
ROIC Less NNEP Spread (ROIC-NNEP)		 8.01% 3.86% 13.91% 15.36% 13.61% -39.04% 30.49% 27.93% -9.01% -13.11% -11.22%
Return on Net Nonoperating Assets (RNNOA)		 0.28% -0.38% -3.64% -4.74% -4.85% 19.63% -18.81% -15.71% 5.10% 7.62% 5.52%
Return on Equity (ROE)		 14.18% -2.88% 10.27% 11.47% 10.36% -26.68% 13.25% 12.59% -2.97% -32.53% -16.26%
Cash Return on Invested Capital (CROIC)		 -1.80% 32.35% 11.66% 19.83% 13.80% 52.19% -17.33% 33.67% -4.44% 10.85% -60.98%
Operating Return on Assets (OROA)		 8.41% -1.42% 6.93% 6.65% 5.88% -16.52% 6.80% 7.03% -2.49% -11.78% -7.10%
Return on Assets (ROA)		 6.13% -1.28% 4.95% 5.91% 5.60% -13.40% 6.12% 6.07% -1.48% -15.97% -7.30%
Return on Common Equity (ROCE)		 14.18% -2.88% 10.27% 11.47% 10.36% -26.68% 13.25% 12.59% -2.97% -32.53% -16.26%
Return on Equity Simple (ROE_SIMPLE)		 13.30% -2.90% 9.99% 11.12% 10.08% -32.44% 12.50% 12.55% 0.00% -39.87% 0.00%
Net Operating Profit after Tax (NOPAT)		 72 -12 55 64 60 -122 57 61 -17 -65 -33
NOPAT Margin		 2.68% -0.43% 2.21% 2.57% 2.52% -6.63% 2.63% 2.72% -0.88% -4.14% -2.02%
Net Nonoperating Expense Percent (NNEP)		 5.89% -6.35% -0.01% 0.86% 1.60% -7.27% 1.57% 0.38% 0.93% -27.04% -10.56%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 12.34% -3.65% -20.11% -9.59%
Cost of Revenue to Revenue		 76.42% 75.29% 74.71% 73.77% 73.83% 76.13% 74.22% 73.29% 73.45% 74.07% 77.24%
SG&A Expenses to Revenue		 18.40% 19.87% 20.36% 21.63% 21.79% 22.11% 21.36% 22.21% 25.95% 26.21% 22.96%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 19.95% 25.33% 22.20% 23.27% 23.38% 33.34% 22.63% 23.51% 27.80% 31.85% 25.65%
Earnings before Interest and Taxes (EBIT)		 98 -17 78 74 66 -175 68 72 -24 -93 -47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 140 30 124 115 104 -143 96 101 1.97 -63 -18
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.08 1.99 2.05 1.49 1.47 1.56 1.99 1.27 1.04 0.74 0.51
Price to Tangible Book Value (P/TBV)		 9.83 5.97 5.09 3.36 2.92 2.17 2.61 1.63 1.32 0.82 0.65
Price to Revenue (P/Rev)		 0.41 0.38 0.45 0.35 0.39 0.37 0.45 0.28 0.25 0.15 0.09
Price to Earnings (P/E)		 15.62 0.00 20.51 13.43 14.59 0.00 15.92 10.84 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 6.40% 0.00% 4.88% 7.44% 6.85% 0.00% 6.28% 9.22% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.03 2.32 2.44 1.75 1.75 2.81 3.20 1.63 1.10 0.31 0.25
Enterprise Value to Revenue (EV/Rev)		 0.42 0.33 0.39 0.27 0.29 0.20 0.33 0.15 0.12 0.02 0.03
Enterprise Value to EBITDA (EV/EBITDA)		 8.15 30.85 7.97 5.92 6.64 0.00 7.40 3.38 113.05 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 11.63 0.00 12.71 9.21 10.41 0.00 10.38 4.75 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 15.74 0.00 17.78 10.60 11.56 0.00 12.43 5.60 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 15.79 3.51 9.85 5.42 7.36 2.47 34.74 2.85 6.41 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 5.93 21.19 8.67 12.74 2.73 0.00 4.71 0.00 2.15 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.45 0.26 0.21 0.14 0.06 0.00 0.00 0.00 0.00 0.02 0.24
Long-Term Debt to Equity		 0.45 0.26 0.21 0.14 0.06 0.00 0.00 0.00 0.00 0.02 0.24
Financial Leverage		 0.03 -0.10 -0.26 -0.31 -0.36 -0.50 -0.62 -0.56 -0.57 -0.58 -0.49
Leverage Ratio		 2.31 2.25 2.07 1.94 1.85 1.99 2.16 2.07 2.01 2.04 2.23
Compound Leverage Factor		 2.28 2.70 2.07 1.99 1.96 1.97 2.34 2.11 1.74 1.94 2.18
Debt to Total Capital		 31.25% 20.49% 17.35% 11.91% 5.60% 0.00% 0.00% 0.00% 0.00% 2.35% 19.33%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 31.25% 20.49% 17.35% 11.91% 5.60% 0.00% 0.00% 0.00% 0.00% 2.35% 19.33%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 68.75% 79.51% 82.65% 88.09% 94.40% 100.00% 100.00% 100.00% 100.00% 97.65% 80.67%
Debt to EBITDA		 1.74 4.56 0.94 0.70 0.36 0.00 0.00 0.00 0.00 -0.12 -3.70
Net Debt to EBITDA		 0.18 -4.40 -1.23 -1.76 -2.23 0.00 0.00 0.00 0.00 3.08 5.36
Long-Term Debt to EBITDA		 1.74 4.56 0.94 0.70 0.36 0.00 0.00 0.00 0.00 -0.12 -3.70
Debt to NOPAT		 3.37 -11.38 2.10 1.25 0.62 0.00 0.00 0.00 0.00 -0.12 -2.02
Net Debt to NOPAT		 0.35 10.99 -2.73 -3.15 -3.88 0.00 0.00 0.00 0.00 3.00 2.92
Long-Term Debt to NOPAT		 3.37 -11.38 2.10 1.25 0.62 0.00 0.00 0.00 0.00 -0.12 -2.02
Altman Z-Score		 4.23 4.27 4.67 4.45 4.35 2.83 4.32 4.10 3.63 3.16 3.47
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.38 1.70 2.02 1.91 1.83 1.41 1.72 1.77 1.74 1.73 2.15
Quick Ratio		 2.15 1.54 1.90 1.78 1.65 1.27 1.56 1.59 1.54 1.48 1.92
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -9.37 155 47 79 54 138 -31 73 -9.17 18 -91
Operating Cash Flow to CapEx		 391.82% 897.68% 456.03% 737.02% 332.63% 563.55% 58.39% 393.47% 111.12% -70.63% -370.21%
Free Cash Flow to Firm to Interest Expense		 -2.25 21.56 8.47 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 17.33 36.38 18.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 12.90 32.33 14.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 2.32 2.30 2.24 2.25 2.10 1.74 2.16 2.20 1.99 1.99 2.46
Accounts Receivable Turnover		 6.56 6.76 6.90 6.85 6.79 5.95 6.88 6.75 6.73 6.71 7.09
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 45.34 45.27 40.41 42.42 38.26 26.78 27.20 24.51 18.99 16.12 19.86
Accounts Payable Turnover		 34.34 30.35 30.76 31.48 26.81 22.16 23.79 21.48 21.05 22.76 30.55
Days Sales Outstanding (DSO)		 55.61 54.01 52.88 53.28 53.75 61.35 53.08 54.09 54.27 54.40 51.49
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 10.63 12.03 11.86 11.59 13.61 16.47 15.34 16.99 17.34 16.03 11.95
Cash Conversion Cycle (CCC)		 44.98 41.99 41.01 41.69 40.14 44.88 37.74 37.10 36.92 38.37 39.54
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 561 394 403 389 395 134 222 211 203 121 179
Invested Capital Turnover		 5.18 5.76 6.29 6.31 6.05 6.98 12.20 10.42 9.22 9.69 10.78
Increase / (Decrease) in Invested Capital		 82 -166 8.95 -14 5.53 -260 88 -12 -7.52 -82 59
Enterprise Value (EV)		 1,138 916 986 681 689 377 710 343 223 38 44
Market Capitalization		 1,113 1,047 1,137 883 920 680 981 629 478 233 139
Book Value per Share		 $12.76 $12.36 $13.41 $14.61 $16.07 $12.32 $13.90 $15.17 $14.70 $10.67 $9.17
Tangible Book Value per Share		 $2.70 $4.13 $5.40 $6.49 $8.08 $8.83 $10.61 $11.81 $11.66 $9.64 $7.15
Total Capital		 779 661 671 671 663 437 493 496 458 323 340
Total Debt		 243 135 116 80 37 0.00 0.00 0.00 0.00 7.60 66
Total Long-Term Debt		 243 135 116 80 37 0.00 0.00 0.00 0.00 7.60 66
Net Debt		 25 -131 -152 -202 -231 -303 -271 -286 -255 -195 -95
Capital Expenditures (CapEx)		 18 29 22 17 28 27 35 31 31 24 16
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 285 142 187 157 153 47 137 115 89 94 135
Debt-free Net Working Capital (DFNWC)		 315 177 216 204 191 110 187 187 151 117 159
Net Working Capital (NWC)		 315 177 216 204 191 110 187 187 151 117 159
Net Nonoperating Expense (NNE)		 1.03 3.35 0.01 -1.52 -3.48 19 -4.51 -1.04 -2.52 61 15
Net Nonoperating Obligations (NNO)		 25 -131 -152 -202 -231 -303 -271 -286 -255 -195 -95
Total Depreciation and Amortization (D&A)		 42 47 46 41 38 32 28 29 26 30 29
Debt-free, Cash-free Net Working Capital to Revenue		 10.58% 5.15% 7.46% 6.29% 6.47% 2.57% 6.29% 5.11% 4.67% 6.02% 8.33%
Debt-free Net Working Capital to Revenue		 11.69% 6.42% 8.60% 8.17% 8.06% 5.95% 8.58% 8.31% 7.92% 7.46% 9.84%
Net Working Capital to Revenue		 11.69% 6.42% 8.60% 8.17% 8.06% 5.95% 8.58% 8.31% 7.92% 7.46% 9.84%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.73 ($0.37) $1.35 $1.64 $1.63 ($4.01) $1.77 $1.89 ($0.45) ($4.17) ($1.61)
Adjusted Weighted Average Basic Shares Outstanding		 41.23M 41.65M 41.20M 39.99M 38.78M 35.37M 34.80M 32.89M 31.32M 30.18M 29.85M
Adjusted Diluted Earnings per Share		 $1.71 ($0.37) $1.34 $1.63 $1.61 ($4.01) $1.74 $1.86 ($0.45) ($4.17) ($1.61)
Adjusted Weighted Average Diluted Shares Outstanding		 41.62M 41.65M 41.44M 40.28M 39.18M 35.37M 35.43M 33.45M 31.32M 30.18M 29.85M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 42.03M 42.18M 41.09M 40.07M 38.63M 35.49M 34.46M 32.82M 31.39M 29.71M 30.06M
Normalized Net Operating Profit after Tax (NOPAT)		 72 61 55 64 60 0.21 57 61 -10 -23 -20
Normalized NOPAT Margin		 2.68% 2.20% 2.21% 2.57% 2.52% 0.01% 2.63% 2.72% -0.53% -1.48% -1.22%
Pre Tax Income Margin		 3.58% -0.74% 3.09% 3.03% 2.96% -9.38% 3.40% 3.26% -1.08% -5.65% -2.82%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 23.52 -2.37 14.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 17.37 -1.66 10.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 19.10 -6.42 10.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 12.95 -5.71 6.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -37.69% 66.14% 52.95% 61.56% -36.90% 27.06% 97.86% -241.15% -16.93% 0.00%

Quarterly Metrics And Ratios for TrueBlue

This table displays calculated financial ratios and metrics derived from TrueBlue's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/24/2023 12/31/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026
DEI Shares Outstanding		 31,004,802.00 31,139,746.00 31,139,746.00 30,569,641.00 29,827,117.00 - 29,707,861.00 29,864,024.00 29,900,868.00 29,939,468.00 30,062,641.00
DEI Adjusted Shares Outstanding		 31,004,802.00 31,139,746.00 31,139,746.00 30,569,641.00 29,827,117.00 - 29,707,861.00 29,864,024.00 29,900,868.00 29,939,468.00 30,062,641.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.04 -0.07 -0.06 -3.42 -0.24 - -0.48 0.02 -0.07 -1.05 -0.66
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -17.81% -11.75% -13.42% -16.69% -19.20% -21.58% -8.09% 0.02% 12.79% 8.35% 7.65%
EBITDA Growth		 -88.08% -111.89% -501.62% -16,831.13% -84.80% -105.96% -19.62% 114.77% 949.57% -542.83% -73.48%
EBIT Growth		 -109.42% -225.77% -182.21% -873.89% -173.20% -20.61% -0.14% 99.93% 81.12% -182.84% -37.97%
NOPAT Growth		 -109.49% -187.36% -160.96% -814.58% -153.23% -20.61% 8.94% 95.10% 97.89% -182.84% -26.37%
Net Income Growth		 -100.05% -136.21% 60.41% -1,329.88% -76,250.00% -358.84% -744.99% 99.85% 74.91% -169.42% -37.96%
EPS Growth		 -100.00% -138.10% 61.54% -1,337.50% 0.00% -412.50% -860.00% 99.71% 76.92% -158.54% -37.50%
Operating Cash Flow Growth		 -104.80% -62.44% -255.60% -115.56% -450.35% -59.62% -55.31% -546.96% -177.33% -171.24% 55.78%
Free Cash Flow Firm Growth		 1,464.94% -91.98% -467.12% 13.77% 236.62% 4,959.80% 278.67% -301.70% -196.19% -205.50% -149.07%
Invested Capital Growth		 -10.11% -3.57% 7.06% -35.44% -37.10% -40.64% -24.96% 42.99% 53.15% 48.75% 5.92%
Revenue Q/Q Growth		 -0.50% 4.01% -18.15% -1.64% -3.50% 0.94% -4.07% 7.03% 8.82% -3.03% -4.69%
EBITDA Q/Q Growth		 1,174.17% -143.63% -254.50% -748.92% 101.16% -691.11% -105.90% 204.83% -17.74% -462.04% 44.43%
EBIT Q/Q Growth		 60.92% -269.22% -61.28% -318.54% 89.04% -63.01% -33.90% 99.73% -3,071.05% -2,341.83% 34.68%
NOPAT Q/Q Growth		 58.42% -216.40% -79.81% -286.61% 88.49% -50.70% -35.76% 79.18% 95.04% -20,053.42% 39.35%
Net Income Q/Q Growth		 99.86% -25,410.00% 33.44% -6,066.67% 92.71% -53.31% -22.58% 98.88% -1,097.50% -1,545.93% 37.23%
EPS Q/Q Growth		 100.00% 0.00% 37.50% -6,800.00% 92.46% -57.69% -17.07% 97.92% -500.00% -1,666.67% 37.74%
Operating Cash Flow Q/Q Growth		 -111.06% 1,272.59% -193.77% 87.20% -290.95% 186.03% -460.71% 46.67% -67.59% 77.90% -123.88%
Free Cash Flow Firm Q/Q Growth		 -12.43% -93.18% -1,815.93% 210.96% 159.09% 2.57% -39.41% -225.26% -23.56% -12.50% 71.82%
Invested Capital Q/Q Growth		 6.25% -3.65% 9.46% -42.39% 3.52% -9.07% 38.37% 9.77% 10.88% -11.68% -1.47%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 26.24% 26.06% 24.67% 26.35% 26.16% 26.57% 23.32% 23.61% 22.70% 21.53% 19.83%
EBITDA Margin		 0.81% -0.34% -1.48% -12.75% 0.15% -0.90% -1.92% 1.88% 1.42% -5.32% -3.10%
Operating Margin		 -0.58% -1.75% -3.85% -15.13% -1.81% -2.70% -3.81% -0.74% -0.03% -7.04% -4.48%
EBIT Margin		 -0.49% -1.75% -3.45% -14.69% -1.67% -2.70% -3.76% -0.01% -0.28% -7.04% -4.82%
Profit (Net Income) Margin		 0.00% -0.52% -0.42% -26.43% -2.00% -3.03% -3.88% -0.04% -0.44% -7.54% -4.97%
Tax Burden Percent		 0.43% 34.46% 12.21% 179.86% 119.63% 116.90% 103.00% 421.05% 159.00% 103.54% 103.00%
Interest Burden Percent		 100.00% 85.82% 100.00% 100.00% 100.00% 96.25% 100.00% 100.00% 100.00% 103.51% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -3.57% -11.31% -23.12% -114.56% -12.33% -18.28% -21.07% -5.13% -0.22% -53.10% -30.02%
ROIC Less NNEP Spread (ROIC-NNEP)		 -4.33% -12.60% -26.91% -87.61% -11.05% -16.32% -18.59% -6.27% 1.00% -45.56% -23.23%
Return on Net Nonoperating Assets (RNNOA)		 2.29% 7.14% 14.25% 51.50% 6.21% 9.49% 8.93% 3.24% -0.47% 22.41% 8.94%
Return on Equity (ROE)		 -1.28% -4.17% -8.87% -63.06% -6.11% -8.79% -12.14% -1.89% -0.69% -30.69% -21.08%
Cash Return on Invested Capital (CROIC)		 8.01% -4.44% -17.70% 5.82% 8.43% 10.85% -4.38% -50.85% -53.51% -60.98% -26.28%
Operating Return on Assets (OROA)		 -1.03% -3.48% -6.97% -31.45% -3.45% -5.37% -7.40% -0.02% -0.64% -17.31% -12.08%
Return on Assets (ROA)		 0.00% -1.03% -0.85% -56.57% -4.13% -6.04% -7.62% -0.09% -1.01% -18.55% -12.44%
Return on Common Equity (ROCE)		 -1.28% -4.17% -8.87% -63.06% -6.11% -8.79% -12.14% -1.89% -0.69% -30.69% -21.08%
Return on Equity Simple (ROE_SIMPLE)		 -1.00% 0.00% -2.59% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.91 -6.04 -11 -42 -4.83 -7.28 -9.89 -2.06 -0.10 -21 -12
NOPAT Margin		 -0.40% -1.23% -2.69% -10.59% -1.26% -1.89% -2.67% -0.52% -0.02% -4.93% -3.13%
Net Nonoperating Expense Percent (NNEP)		 0.76% 1.29% 3.78% -26.95% -1.27% -1.97% -2.48% 1.14% -1.23% -7.54% -6.79%
Return On Investment Capital (ROIC_SIMPLE)		 - -1.32% -2.43% -12.43% -1.48% -2.25% -2.75% -0.57% -0.03% -6.05% -3.79%
Cost of Revenue to Revenue		 73.76% 73.94% 75.33% 73.65% 73.84% 73.43% 76.68% 76.39% 77.30% 78.47% 80.17%
SG&A Expenses to Revenue		 25.51% 26.41% 26.54% 24.49% 26.15% 27.71% 25.56% 22.66% 21.27% 22.70% 21.90%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 26.82% 27.82% 28.52% 41.49% 27.97% 29.27% 27.13% 24.35% 22.73% 28.57% 24.30%
Earnings before Interest and Taxes (EBIT)		 -2.34 -8.63 -14 -58 -6.38 -10 -14 -0.04 -1.21 -29 -19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 3.85 -1.68 -5.95 -51 0.59 -3.46 -7.12 7.46 6.14 -22 -12
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.98 1.04 0.87 0.93 0.69 0.74 0.55 0.65 0.61 0.51 0.39
Price to Tangible Book Value (P/TBV)		 1.24 1.32 1.10 1.03 0.77 0.82 0.69 0.82 0.77 0.65 0.50
Price to Revenue (P/Rev)		 0.23 0.25 0.21 0.18 0.14 0.15 0.11 0.13 0.12 0.09 0.06
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.95 1.10 0.75 0.82 0.25 0.31 0.18 0.42 0.42 0.25 0.11
Enterprise Value to Revenue (EV/Rev)		 0.10 0.12 0.09 0.06 0.02 0.02 0.02 0.05 0.05 0.03 0.01
Enterprise Value to EBITDA (EV/EBITDA)		 11.27 113.05 0.00 0.00 0.00 0.00 0.00 0.00 86.15 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 3.34 6.41 14.58 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 11.23 0.00 0.00 11.06 2.26 2.15 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.02 0.19 0.18 0.22 0.24 0.29
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.02 0.19 0.18 0.22 0.24 0.29
Financial Leverage		 -0.53 -0.57 -0.53 -0.59 -0.56 -0.58 -0.48 -0.52 -0.47 -0.49 -0.39
Leverage Ratio		 2.01 2.01 2.00 2.08 2.06 2.04 2.09 2.17 2.21 2.23 2.35
Compound Leverage Factor		 2.01 1.73 2.00 2.08 2.06 1.96 2.09 2.17 2.21 2.31 2.35
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 2.35% 16.05% 14.99% 18.31% 19.33% 22.40%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 2.35% 16.05% 14.99% 18.31% 19.33% 22.40%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 97.65% 83.95% 85.01% 81.69% 80.67% 77.60%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -0.12 -0.92 -8.75 68.96 -3.70 -3.45
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 3.08 2.15 19.88 -102.51 5.36 3.70
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -0.12 -0.92 -8.75 68.96 -3.70 -3.45
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -0.12 -0.90 -2.24 -3.53 -2.02 -2.10
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 3.00 2.12 5.08 5.25 2.92 2.25
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -0.12 -0.90 -2.24 -3.53 -2.02 -2.10
Altman Z-Score		 3.67 3.68 3.56 3.59 3.63 3.57 3.28 3.53 3.51 3.56 3.64
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.79 1.74 1.71 1.90 1.85 1.73 1.80 1.94 2.01 2.15 2.09
Quick Ratio		 1.61 1.54 1.52 1.63 1.55 1.48 1.55 1.67 1.75 1.92 1.88
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 22 1.49 -26 28 73 75 46 -57 -71 -79 -22
Operating Cash Flow to CapEx		 -17.60% 185.61% -193.07% -30.88% -127.38% 116.18% -472.54% -277.11% -546.60% -139.73% -345.67%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 2.08 1.99 2.02 2.14 2.07 1.99 1.97 2.20 2.27 2.46 2.50
Accounts Receivable Turnover		 6.52 6.73 7.01 7.07 6.67 6.71 6.63 6.72 6.64 7.09 7.07
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 20.21 18.99 18.22 18.34 17.26 16.12 15.96 17.32 18.32 19.86 20.90
Accounts Payable Turnover		 28.16 21.05 25.31 30.90 29.33 22.76 27.96 31.49 32.00 30.55 32.99
Days Sales Outstanding (DSO)		 56.00 54.27 52.08 51.61 54.70 54.40 55.08 54.32 54.99 51.49 51.65
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 12.96 17.34 14.42 11.81 12.44 16.03 13.05 11.59 11.41 11.95 11.07
Cash Conversion Cycle (CCC)		 43.03 36.92 37.66 39.80 42.25 38.37 42.03 42.72 43.59 39.54 40.59
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 211 203 222 128 133 121 167 183 203 179 177
Invested Capital Turnover		 8.86 9.22 8.58 10.82 9.75 9.69 7.89 9.87 9.44 10.78 9.58
Increase / (Decrease) in Invested Capital		 -24 -7.52 15 -70 -78 -82 -55 55 70 59 9.87
Enterprise Value (EV)		 200 223 166 105 33 38 31 77 85 44 20
Market Capitalization		 446 478 390 315 227 233 166 199 187 139 100
Book Value per Share		 $14.73 $14.70 $14.35 $11.05 $10.97 $10.67 $10.17 $10.22 $10.18 $9.17 $8.52
Tangible Book Value per Share		 $11.61 $11.66 $11.37 $10.00 $9.91 $9.64 $8.06 $8.14 $8.14 $7.15 $6.64
Total Capital		 457 458 446 338 327 323 360 359 373 340 330
Total Debt		 0.00 0.00 0.00 0.00 0.00 7.60 58 54 68 66 74
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 7.60 58 54 68 66 74
Net Debt		 -246 -255 -224 -210 -195 -195 -135 -122 -101 -95 -79
Capital Expenditures (CapEx)		 7.36 8.18 7.38 5.90 5.60 5.28 4.68 4.26 3.62 3.13 2.83
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 112 89 95 116 116 94 102 117 138 135 133
Debt-free Net Working Capital (DFNWC)		 159 151 131 143 131 117 125 139 158 159 157
Net Working Capital (NWC)		 159 151 131 143 131 117 125 139 158 159 157
Net Nonoperating Expense (NNE)		 -1.90 -3.49 -9.16 63 2.80 4.42 4.46 -1.90 1.81 11 7.30
Net Nonoperating Obligations (NNO)		 -246 -255 -224 -210 -195 -195 -135 -122 -101 -95 -79
Total Depreciation and Amortization (D&A)		 6.18 6.95 7.96 7.69 6.97 6.95 6.81 7.50 7.35 7.20 6.87
Debt-free, Cash-free Net Working Capital to Revenue		 5.68% 4.67% 5.17% 6.59% 6.94% 6.02% 6.62% 7.62% 8.69% 8.33% 8.11%
Debt-free Net Working Capital to Revenue		 8.07% 7.92% 7.13% 8.09% 7.81% 7.46% 8.13% 9.04% 9.95% 9.84% 9.57%
Net Working Capital to Revenue		 8.07% 7.92% 7.13% 8.09% 7.81% 7.46% 8.13% 9.04% 9.95% 9.84% 9.57%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.08) ($0.05) ($3.45) ($0.26) ($0.41) ($0.48) ($0.01) ($0.06) ($1.06) ($0.66)
Adjusted Weighted Average Basic Shares Outstanding		 30.93M 31.32M 31.10M 30.35M 29.70M 30.18M 29.70M 29.86M 29.90M 29.85M 30.15M
Adjusted Diluted Earnings per Share		 $0.00 ($0.08) ($0.05) ($3.45) ($0.26) ($0.41) ($0.48) ($0.01) ($0.06) ($1.06) ($0.66)
Adjusted Weighted Average Diluted Shares Outstanding		 30.93M 31.32M 31.10M 30.35M 29.70M 30.18M 29.70M 29.86M 29.90M 29.85M 30.15M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 31.14M 31.39M 30.57M 29.83M 29.56M 29.71M 29.86M 29.90M 29.94M 30.06M 30.40M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.91 -6.04 -11 -0.20 -4.83 -7.28 -9.89 -1.92 -0.10 -21 -9.93
Normalized NOPAT Margin		 -0.40% -1.23% -2.69% -0.05% -1.26% -1.89% -2.67% -0.48% -0.02% -4.93% -2.49%
Pre Tax Income Margin		 -0.49% -1.50% -3.45% -14.69% -1.67% -2.59% -3.76% -0.01% -0.28% -7.28% -4.82%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -746.73% -241.15% -168.60% -15.57% -18.27% -16.93% 0.00% -12.72% 0.03% 0.00% 0.00%

Financials Breakdown Chart

TrueBlue Financials - Frequently Asked Questions

According to the most recent income statement we have on file, TrueBlue's financial year ends in December. Their financial year 2025 ended on December 28, 2025.

TrueBlue's net income appears to be on a downward trend, with a most recent value of -$47.96 million in 2025, falling from $71.25 million in 2015. The previous period was -$125.75 million in 2024. Find out what analysts predict for TrueBlue in the coming months.

TrueBlue's total operating income in 2025 was -$46.63 million, based on the following breakdown:
  • Total Gross Profit: $367.84 million
  • Total Operating Expenses: $414.48 million

Over the last 10 years, TrueBlue's total revenue changed from $2.70 billion in 2015 to $1.62 billion in 2025, a change of -40.1%.

TrueBlue's total liabilities were at $364.11 million at the end of 2025, a 1.1% increase from 2024, and a 49.7% decrease since 2015.

In the past 10 years, TrueBlue's cash and equivalents has ranged from $22.54 million in 2024 to $72.05 million in 2022, and is currently $24.51 million as of their latest financial filing in 2025.

Over the last 10 years, TrueBlue's book value per share changed from 12.76 in 2015 to 9.17 in 2025, a change of -28.1%.


Related Companies

Financial statements for NYSE:TBI last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel